Skip to Content
U.S. National Institutes of Health
Cancer Diagnosis Program Cancer Imaging Program Cancer Therapy Evaluation Program Developmental Therapeutics Program Radiation Research Program Translational Research Program Biometric Research Branch Office of Cancer Complementary and Alternative Medicine
Last Updated: 04/25/2012


Accelerating Clinical Trials of Novel Oncologic PathWays (ACTNOW)

Among the many programs NCI has designated for funding from American Recovery and Reinvestment Act of 2009 is the phase 1-2 clinical trials program ACTNOW (Accelerating Clinical Trials of Novel Oncologic Pathways). It holds great promise for shortening the time it takes to move new cancer therapies from discovery, to development, to approval and safe use by adult and pediatric cancer patients. The program is designed to play a significant role in enabling NCI's goal of developing personalized cancer medicine and an enhanced drug development platform.